Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Euro falls against Canadian Dollar amid French debt fears, oil rally

Euro falls against Canadian Dollar amid French debt fears, oil rally

FXStreetFXStreet2026/10/08 09:45

EUR/CAD continues its losing streak for the fourth successive day, trading around 1.5940 during European hours on Thursday. The currency cross has depreciated as the Euro (EUR) faces ongoing pressure driven by fiscal instability in France and broader contagion fears across the Eurozone.

Concerns over Paris's ability to rein in its budget deficit triggered a sharp bond market selloff, driving the risk premium on French government debt to its highest level since the Eurozone debt crisis. As investors shed French bonds in favor of safer German bunds, French Prime Minister Sébastien Lecornu's minority government announced a €54bn savings package last month to avert a catastrophic credit downgrade or sovereign default.

Adding to the Euro's headwinds, Germany’s Trade Surplus narrowed to €19.5 billion in August from a revised two-and-a-half-year high of €21.6 billion in July, though it slightly topped market expectations of €19 billion. The narrowing was driven by an unexpected 0.8% month-on-month drop in exports, defying forecasts for a 0.8% increase, alongside a 0.9% rebound in imports following a steep decline in the prior month.

Meanwhile, the EUR/CAD cross remains under pressure as the commodity-linked Canadian Dollar (CAD) benefits from a surge in global crude oil prices. Energy markets rallied on reports that the Trump administration directed the Pentagon to draft military strike options against Iran ahead of the US midterm elections, confounding expectations of a pre-election de-escalation.

Oil prices received further upward momentum from supply disruptions in the Gulf of Mexico caused by Tropical Storm Isaias. Offshore producers were forced to shut in over 510,000 barrels per day of crude production, taking approximately a quarter of the region’s total output offline and offering additional support to the CAD.

Canada faces rising political fragmentation as separatist risks resurface

Analysts at Rabobank highlight growing political strains in Canada, noting that “the separatist Parti Québécois won around 30 percent of the vote in Monday’s provincial election, gaining 59 of 127 seats—just shy of a majority but enough to form a minority government.” They add that the picture is complicated further by developments in the west, where “Alberta will vote on its own independence (or at least, the process to start considering independence) from Canada on October 19,” underscoring a rise in regional fragmentation that could add to the country’s political risk profile.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46

SuperX AI Technology's stock price declined, falling more than 2.5% at one point.

智通财经•2026/10/08 16:11

BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars

Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)

路透社•2026/10/08 16:11